RU2684306C2 - Обогащенная питательная среда для выращивания клеток, извлеченных из ткани пуповины человека - Google Patents

Info

Publication number

RU2684306C2

RU2684306C2 RU2018112452A RU2018112452A RU2684306C2 RU 2684306 C2 RU2684306 C2 RU 2684306C2 RU 2018112452 A RU2018112452 A RU 2018112452A RU 2018112452 A RU2018112452 A RU 2018112452A RU 2684306 C2 RU2684306 C2 RU 2684306C2

Authority

RU

Russia

Prior art keywords

cells

culture medium

cell

medium

microcarriers

Prior art date

2012-12-14

Links

• Espacenet
• Global Dossier
• Discuss

• 241000282414 Homo sapiens Species 0.000 title claims abstract description 44
• 210000003954 umbilical cord Anatomy 0.000 title claims description 81
• 235000015097 nutrients Nutrition 0.000 title description 94
• 239000001963 growth medium Substances 0.000 claims abstract description 191
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims abstract description 54
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 54
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 54
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 54
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 54
• RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims abstract description 54
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 52
• 239000000758 substrate Substances 0.000 claims abstract description 49
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 47
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 44
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 44
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 43
• 230000001419 dependent effect Effects 0.000 claims abstract description 42
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 41
• 235000002639 sodium chloride Nutrition 0.000 claims abstract description 41
• LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 40
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 36
• RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 36
• 229940088594 vitamin Drugs 0.000 claims abstract description 35
• 229930003231 vitamin Natural products 0.000 claims abstract description 35
• 235000013343 vitamin Nutrition 0.000 claims abstract description 35
• 239000011782 vitamin Substances 0.000 claims abstract description 35
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 34
• 229940024606 amino acid Drugs 0.000 claims abstract description 34
• 235000001014 amino acid Nutrition 0.000 claims abstract description 34
• 150000001413 amino acids Chemical class 0.000 claims abstract description 34
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 32
• KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims abstract description 32
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 31
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 31
• 229930182816 L-glutamine Natural products 0.000 claims abstract description 31
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 31
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 31
• 230000012010 growth Effects 0.000 claims abstract description 31
• 239000008103 glucose Substances 0.000 claims abstract description 29
• XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 29
• 150000003839 salts Chemical class 0.000 claims abstract description 28
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims abstract description 28
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims abstract description 27
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims abstract description 27
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 27
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 27
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 27
• 229930064664 L-arginine Natural products 0.000 claims abstract description 27
• 235000014852 L-arginine Nutrition 0.000 claims abstract description 27
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims abstract description 27
• 239000004158 L-cystine Substances 0.000 claims abstract description 27
• 235000019393 L-cystine Nutrition 0.000 claims abstract description 27
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 27
• 229930182844 L-isoleucine Natural products 0.000 claims abstract description 27
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 27
• 229960003767 alanine Drugs 0.000 claims abstract description 27
• 229960001230 asparagine Drugs 0.000 claims abstract description 27
• 229960003067 cystine Drugs 0.000 claims abstract description 27
• 229960002989 glutamic acid Drugs 0.000 claims abstract description 27
• 229960000310 isoleucine Drugs 0.000 claims abstract description 27
• 229960005190 phenylalanine Drugs 0.000 claims abstract description 27
• 229960004799 tryptophan Drugs 0.000 claims abstract description 27
• 229960004441 tyrosine Drugs 0.000 claims abstract description 27
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 26
• CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims abstract description 26
• CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims abstract description 26
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 26
• 229960005261 aspartic acid Drugs 0.000 claims abstract description 26
• 229960002885 histidine Drugs 0.000 claims abstract description 26
• 239000004472 Lysine Substances 0.000 claims abstract description 24
• FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims abstract description 23
• 235000019766 L-Lysine Nutrition 0.000 claims abstract description 23
• 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 22
• 235000019743 Choline chloride Nutrition 0.000 claims abstract description 22
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 22
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 22
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 22
• FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 22
• SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 22
• 229960003178 choline chloride Drugs 0.000 claims abstract description 22
• 235000000639 cyanocobalamin Nutrition 0.000 claims abstract description 22
• 239000011666 cyanocobalamin Substances 0.000 claims abstract description 22
• 229960002104 cyanocobalamin Drugs 0.000 claims abstract description 22
• 229960002433 cysteine Drugs 0.000 claims abstract description 22
• 229940068840 d-biotin Drugs 0.000 claims abstract description 22
• 229960000304 folic acid Drugs 0.000 claims abstract description 22
• 235000019152 folic acid Nutrition 0.000 claims abstract description 22
• 239000011724 folic acid Substances 0.000 claims abstract description 22
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 22
• 229960003966 nicotinamide Drugs 0.000 claims abstract description 22
• 235000005152 nicotinamide Nutrition 0.000 claims abstract description 22
• 239000011570 nicotinamide Substances 0.000 claims abstract description 22
• 229960002477 riboflavin Drugs 0.000 claims abstract description 22
• 235000019192 riboflavin Nutrition 0.000 claims abstract description 22
• 239000002151 riboflavin Substances 0.000 claims abstract description 22
• KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 22
• 229960003495 thiamine Drugs 0.000 claims abstract description 22
• 229940011671 vitamin b6 Drugs 0.000 claims abstract description 22
• 239000004201 L-cysteine Substances 0.000 claims abstract description 21
• 235000013878 L-cysteine Nutrition 0.000 claims abstract description 21
• JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 21
• 235000019157 thiamine Nutrition 0.000 claims abstract description 21
• 239000011721 thiamine Substances 0.000 claims abstract description 21
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 18
• CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 18
• 229960003581 pyridoxal Drugs 0.000 claims abstract description 18
• 235000008164 pyridoxal Nutrition 0.000 claims abstract description 18
• 239000011674 pyridoxal Substances 0.000 claims abstract description 18
• 235000008160 pyridoxine Nutrition 0.000 claims abstract description 18
• 239000011677 pyridoxine Substances 0.000 claims abstract description 18
• 239000011573 trace mineral Substances 0.000 claims abstract description 17
• 235000013619 trace mineral Nutrition 0.000 claims abstract description 17
• 239000001110 calcium chloride Substances 0.000 claims abstract description 16
• 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 16
• 239000001103 potassium chloride Substances 0.000 claims abstract description 16
• 235000011164 potassium chloride Nutrition 0.000 claims abstract description 16
• 239000005700 Putrescine Substances 0.000 claims abstract description 15
• 229940054269 sodium pyruvate Drugs 0.000 claims abstract description 14
• 239000011780 sodium chloride Substances 0.000 claims abstract description 13
• 239000001488 sodium phosphate Substances 0.000 claims abstract description 10
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims abstract description 10
• 239000000395 magnesium oxide Substances 0.000 claims abstract description 9
• 229910000162 sodium phosphate Inorganic materials 0.000 claims abstract description 9
• 239000003381 stabilizer Substances 0.000 claims abstract description 9
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 8
• 229930182821 L-proline Natural products 0.000 claims abstract description 7
• 229960002429 proline Drugs 0.000 claims abstract description 7
• 239000002518 antifoaming agent Substances 0.000 claims abstract description 6
• 229910000365 copper sulfate Inorganic materials 0.000 claims abstract description 4
• ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 4
• NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 4
• 229960001763 zinc sulfate Drugs 0.000 claims abstract description 4
• 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 4
• 210000004027 cell Anatomy 0.000 claims description 713
• 239000002609 medium Substances 0.000 claims description 140
• 210000001519 tissue Anatomy 0.000 claims description 110
• 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 109
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 63
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 58
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 56
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 56
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims description 54
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 46
• 235000019136 lipoic acid Nutrition 0.000 claims description 46
• 229960002663 thioctic acid Drugs 0.000 claims description 46
• AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 42
• 102000004877 Insulin Human genes 0.000 claims description 31
• 108090001061 Insulin Proteins 0.000 claims description 31
• 229940125396 insulin Drugs 0.000 claims description 31
• 102000004338 Transferrin Human genes 0.000 claims description 30
• 108090000901 Transferrin Proteins 0.000 claims description 30
• 239000012581 transferrin Substances 0.000 claims description 30
• 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 28
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 28
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 28
• 229960005305 adenosine Drugs 0.000 claims description 28
• 229940029575 guanosine Drugs 0.000 claims description 28
• 210000000130 stem cell Anatomy 0.000 claims description 28
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims description 27
• -1 sodium phosphate, dibasic heptahydrate Chemical class 0.000 claims description 27
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims description 27
• 229940045145 uridine Drugs 0.000 claims description 27
• UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims description 26
• UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims description 26
• UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims description 26
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 24
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 24
• 229940104230 thymidine Drugs 0.000 claims description 24
• AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 23
• 239000002777 nucleoside Chemical class 0.000 claims description 23
• 229940098773 bovine serum albumin Drugs 0.000 claims description 21
• 125000003835 nucleoside group Chemical class 0.000 claims description 21
• 239000011734 sodium Substances 0.000 claims description 21
• 102100022749 Aminopeptidase N Human genes 0.000 claims description 20
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims description 20
• 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims description 20
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 20
• FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 20
• BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 19
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 19
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 18
• 235000015921 sodium selenite Nutrition 0.000 claims description 18
• 239000011781 sodium selenite Substances 0.000 claims description 18
• 229960001471 sodium selenite Drugs 0.000 claims description 18
• 230000004069 differentiation Effects 0.000 claims description 17
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 16
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 16
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 16
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 16
• 210000004369 blood Anatomy 0.000 claims description 16
• 239000008280 blood Substances 0.000 claims description 16
• JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 15
• 229940076153 heptahydrate zinc sulfate Drugs 0.000 claims description 15
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 14
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 14
• 229940061607 dibasic sodium phosphate Drugs 0.000 claims description 14
• 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 14
• 229940045641 monobasic sodium phosphate Drugs 0.000 claims description 13
• 229910052760 oxygen Inorganic materials 0.000 claims description 13
• 210000001185 bone marrow Anatomy 0.000 claims description 12
• 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 11
• 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 11
• 229940126864 fibroblast growth factor Drugs 0.000 claims description 10
• 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 9
• 235000019341 magnesium sulphate Nutrition 0.000 claims description 9
• MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 claims description 8
• 102000009027 Albumins Human genes 0.000 claims description 4
• 108010088751 Albumins Proteins 0.000 claims description 4
• 239000003795 chemical substances by application Substances 0.000 claims description 4
• 210000004381 amniotic fluid Anatomy 0.000 claims description 3
• 239000006143 cell culture medium Substances 0.000 claims description 3
• 210000003074 dental pulp Anatomy 0.000 claims description 3
• 210000005059 placental tissue Anatomy 0.000 claims description 3
• 230000001464 adherent effect Effects 0.000 claims description 2
• 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 230000000694 effects Effects 0.000 abstract description 9
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 5
• 239000000126 substance Substances 0.000 abstract description 4
• 229930003270 Vitamin B Natural products 0.000 abstract 1
• 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
• 239000011720 vitamin B Substances 0.000 abstract 1
• 235000019156 vitamin B Nutrition 0.000 abstract 1
• 239000000243 solution Substances 0.000 description 131
• 238000000034 method Methods 0.000 description 114
• 239000012091 fetal bovine serum Substances 0.000 description 87
• 210000002966 serum Anatomy 0.000 description 46
• 239000000203 mixture Substances 0.000 description 41
• 108090000623 proteins and genes Proteins 0.000 description 38
• 229960001031 glucose Drugs 0.000 description 37
• 108060005980 Collagenase Proteins 0.000 description 31
• 102000029816 Collagenase Human genes 0.000 description 31
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 31
• 102000004190 Enzymes Human genes 0.000 description 29
• 108090000790 Enzymes Proteins 0.000 description 29
• 229960002424 collagenase Drugs 0.000 description 29
• 229940088598 enzyme Drugs 0.000 description 29
• 239000002054 inoculum Substances 0.000 description 25
• 108010007093 dispase Proteins 0.000 description 24
• 230000014509 gene expression Effects 0.000 description 24
• 238000004458 analytical method Methods 0.000 description 23
• 235000018102 proteins Nutrition 0.000 description 23
• 102000004169 proteins and genes Human genes 0.000 description 23
• 229910002091 carbon monoxide Inorganic materials 0.000 description 22
• 238000004519 manufacturing process Methods 0.000 description 22
• 239000000463 material Substances 0.000 description 22
• 108010010803 Gelatin Proteins 0.000 description 20
• 229920000159 gelatin Polymers 0.000 description 20
• 239000008273 gelatin Substances 0.000 description 20
• 235000019322 gelatine Nutrition 0.000 description 20
• 235000011852 gelatine desserts Nutrition 0.000 description 20
• 102000001974 Hyaluronidases Human genes 0.000 description 19
• 238000002955 isolation Methods 0.000 description 19
• 108010003272 Hyaluronate lyase Proteins 0.000 description 18
• 229960002773 hyaluronidase Drugs 0.000 description 18
• 238000004113 cell culture Methods 0.000 description 16
• 239000000306 component Substances 0.000 description 16
• 210000002950 fibroblast Anatomy 0.000 description 16
• 230000005484 gravity Effects 0.000 description 16
• 235000016709 nutrition Nutrition 0.000 description 16
• 239000002245 particle Substances 0.000 description 16
• 230000008569 process Effects 0.000 description 16
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 16
• 238000012258 culturing Methods 0.000 description 15
• 238000010899 nucleation Methods 0.000 description 15
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
• 230000010261 cell growth Effects 0.000 description 14
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 14
• 238000000684 flow cytometry Methods 0.000 description 14
• 239000002953 phosphate buffered saline Substances 0.000 description 14
• 229920001993 poloxamer 188 Polymers 0.000 description 14
• 102100032912 CD44 antigen Human genes 0.000 description 13
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 13
• 239000012298 atmosphere Substances 0.000 description 13
• 239000007640 basal medium Substances 0.000 description 13
• 239000012888 bovine serum Substances 0.000 description 13
• 230000002255 enzymatic effect Effects 0.000 description 13
• 239000004033 plastic Substances 0.000 description 13
• 229920003023 plastic Polymers 0.000 description 13
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 12
• 102000003729 Neprilysin Human genes 0.000 description 12
• 108090000028 Neprilysin Proteins 0.000 description 12
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 12
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 12
• 238000000926 separation method Methods 0.000 description 12
• 239000006228 supernatant Substances 0.000 description 12
• 102100037362 Fibronectin Human genes 0.000 description 11
• 238000003776 cleavage reaction Methods 0.000 description 11
• 238000011534 incubation Methods 0.000 description 11
• 108020004707 nucleic acids Proteins 0.000 description 11
• 102000039446 nucleic acids Human genes 0.000 description 11
• 230000007017 scission Effects 0.000 description 11
• 238000010257 thawing Methods 0.000 description 11
• 108010067306 Fibronectins Proteins 0.000 description 10
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 10
• 239000006285 cell suspension Substances 0.000 description 10
• 238000000338 in vitro Methods 0.000 description 10
• 238000002156 mixing Methods 0.000 description 10
• 150000007523 nucleic acids Chemical class 0.000 description 10
• 210000002826 placenta Anatomy 0.000 description 10
• 238000007747 plating Methods 0.000 description 10
• 108010035532 Collagen Proteins 0.000 description 9
• 102000008186 Collagen Human genes 0.000 description 9
• 102000007547 Laminin Human genes 0.000 description 9
• 108010085895 Laminin Proteins 0.000 description 9
• 229920001436 collagen Polymers 0.000 description 9
• 239000000523 sample Substances 0.000 description 9
• 102100022464 5'-nucleotidase Human genes 0.000 description 8
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 8
• 229930182555 Penicillin Natural products 0.000 description 8
• 210000002798 bone marrow cell Anatomy 0.000 description 8
• 239000011248 coating agent Substances 0.000 description 8
• 150000002632 lipids Chemical class 0.000 description 8
• 239000008188 pellet Substances 0.000 description 8
• 229940049954 penicillin Drugs 0.000 description 8
• 238000002360 preparation method Methods 0.000 description 8
• 235000011008 sodium phosphates Nutrition 0.000 description 8
• 229960005322 streptomycin Drugs 0.000 description 8
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
• SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 7
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 7
• 108010075704 HLA-A Antigens Proteins 0.000 description 7
• 108700005087 Homeobox Genes Proteins 0.000 description 7
• 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 7
• 102000004890 Interleukin-8 Human genes 0.000 description 7
• 108090001007 Interleukin-8 Proteins 0.000 description 7
• 102100026966 Thrombomodulin Human genes 0.000 description 7
• 108090000631 Trypsin Proteins 0.000 description 7
• 102000004142 Trypsin Human genes 0.000 description 7
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 7
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
• 239000007864 aqueous solution Substances 0.000 description 7
• 238000000576 coating method Methods 0.000 description 7
• 229960000673 dextrose monohydrate Drugs 0.000 description 7
• 229940096397 interleukin-8 Drugs 0.000 description 7
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 7
• 230000008774 maternal effect Effects 0.000 description 7
• 230000035755 proliferation Effects 0.000 description 7
• 230000000644 propagated effect Effects 0.000 description 7
• 238000009331 sowing Methods 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 239000012588 trypsin Substances 0.000 description 7
• PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 6
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 6
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
• 229920002307 Dextran Polymers 0.000 description 6
• 102000035092 Neutral proteases Human genes 0.000 description 6
• 108091005507 Neutral proteases Proteins 0.000 description 6
• 108010017842 Telomerase Proteins 0.000 description 6
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 6
• 229960003942 amphotericin b Drugs 0.000 description 6
• 238000005119 centrifugation Methods 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• PYLIXCKOHOHGKQ-UHFFFAOYSA-L disodium;hydrogen phosphate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O PYLIXCKOHOHGKQ-UHFFFAOYSA-L 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 230000005298 paramagnetic effect Effects 0.000 description 6
• 239000011148 porous material Substances 0.000 description 6
• 239000002243 precursor Substances 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• 235000018716 sodium selenate Nutrition 0.000 description 6
• 239000011655 sodium selenate Substances 0.000 description 6
• 229960001881 sodium selenate Drugs 0.000 description 6
• 238000004114 suspension culture Methods 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
• 229960004295 valine Drugs 0.000 description 6
• 101800003838 Epidermal growth factor Proteins 0.000 description 5
• 108010052014 Liberase Proteins 0.000 description 5
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 5
• 102100022647 Reticulon-1 Human genes 0.000 description 5
• 101710122684 Reticulon-1 Proteins 0.000 description 5
• 150000001412 amines Chemical class 0.000 description 5
• 210000004204 blood vessel Anatomy 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 229940116977 epidermal growth factor Drugs 0.000 description 5
• 210000004700 fetal blood Anatomy 0.000 description 5
• 238000011081 inoculation Methods 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 230000001902 propagating effect Effects 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 102000007469 Actins Human genes 0.000 description 4
• 108010085238 Actins Proteins 0.000 description 4
• 108090000145 Bacillolysin Proteins 0.000 description 4
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 4
• 239000004471 Glycine Substances 0.000 description 4
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 4
• IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 4
• 239000004395 L-leucine Substances 0.000 description 4
• 235000019454 L-leucine Nutrition 0.000 description 4
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
• 229930195722 L-methionine Natural products 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• 241000555745 Sciuridae Species 0.000 description 4
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
• 239000004473 Threonine Substances 0.000 description 4
• 102100035071 Vimentin Human genes 0.000 description 4
• 108010065472 Vimentin Proteins 0.000 description 4
• 108010031318 Vitronectin Proteins 0.000 description 4
• 102100035140 Vitronectin Human genes 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 210000001772 blood platelet Anatomy 0.000 description 4
• 239000011575 calcium Substances 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 238000002659 cell therapy Methods 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 230000003399 chemotactic effect Effects 0.000 description 4
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
• 210000000349 chromosome Anatomy 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 238000010494 dissociation reaction Methods 0.000 description 4
• 230000005593 dissociations Effects 0.000 description 4
• 239000012634 fragment Substances 0.000 description 4
• 239000012737 fresh medium Substances 0.000 description 4
• 210000003714 granulocyte Anatomy 0.000 description 4
• 239000003102 growth factor Substances 0.000 description 4
• 229960003136 leucine Drugs 0.000 description 4
• AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 4
• 239000012139 lysis buffer Substances 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 230000031864 metaphase Effects 0.000 description 4
• 229960004452 methionine Drugs 0.000 description 4
• 210000003205 muscle Anatomy 0.000 description 4
• FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 4
• 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 4
• 239000011764 pyridoxine hydrochloride Substances 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 229960001153 serine Drugs 0.000 description 4
• 210000002460 smooth muscle Anatomy 0.000 description 4
• 229910052708 sodium Inorganic materials 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 229960002898 threonine Drugs 0.000 description 4
• 210000005048 vimentin Anatomy 0.000 description 4
• PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 3
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
• 102000050083 Class E Scavenger Receptors Human genes 0.000 description 3
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
• 102000016911 Deoxyribonucleases Human genes 0.000 description 3
• 108010053770 Deoxyribonucleases Proteins 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 3
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
• 229930182566 Gentamicin Natural products 0.000 description 3
• 102000005741 Metalloproteases Human genes 0.000 description 3
• 108010006035 Metalloproteases Proteins 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 102000035195 Peptidases Human genes 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 108010000499 Thromboplastin Proteins 0.000 description 3
• 102100030859 Tissue factor Human genes 0.000 description 3
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
• 102100031484 Vesicle-associated membrane protein 5 Human genes 0.000 description 3
• 229930003268 Vitamin C Natural products 0.000 description 3
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
• 230000032683 aging Effects 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940088710 antibiotic agent Drugs 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 239000007853 buffer solution Substances 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 239000000648 calcium alginate Substances 0.000 description 3
• 235000010410 calcium alginate Nutrition 0.000 description 3
• 229960002681 calcium alginate Drugs 0.000 description 3
• OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 3
• 239000002458 cell surface marker Substances 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 230000000295 complement effect Effects 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 239000003636 conditioned culture medium Substances 0.000 description 3
• 238000007596 consolidation process Methods 0.000 description 3
• 239000010949 copper Substances 0.000 description 3
• 229910052802 copper Inorganic materials 0.000 description 3
• 238000012364 cultivation method Methods 0.000 description 3
• 230000002559 cytogenic effect Effects 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 230000005611 electricity Effects 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000004088 foaming agent Substances 0.000 description 3
• 229960002518 gentamicin Drugs 0.000 description 3
• 239000011521 glass Substances 0.000 description 3
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 210000005260 human cell Anatomy 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000007758 minimum essential medium Substances 0.000 description 3
• 230000000510 mucolytic effect Effects 0.000 description 3
• 210000000663 muscle cell Anatomy 0.000 description 3
• 229960000988 nystatin Drugs 0.000 description 3
• VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 238000003752 polymerase chain reaction Methods 0.000 description 3
• 238000012545 processing Methods 0.000 description 3
• 108091005418 scavenger receptor class E Proteins 0.000 description 3
• HVAKSLUOHARFLM-UHFFFAOYSA-N selenium;sodium Chemical compound [Se][Na] HVAKSLUOHARFLM-UHFFFAOYSA-N 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• 238000003756 stirring Methods 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 238000002054 transplantation Methods 0.000 description 3
• 235000019154 vitamin C Nutrition 0.000 description 3
• 239000011718 vitamin C Substances 0.000 description 3
• 229910052725 zinc Inorganic materials 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
• 101150028074 2 gene Proteins 0.000 description 2
• PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 2
• 102100024090 Aldo-keto reductase family 1 member C3 Human genes 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• 102100034605 Atrial natriuretic peptide receptor 3 Human genes 0.000 description 2
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102000009410 Chemokine receptor Human genes 0.000 description 2
• 108050000299 Chemokine receptor Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical class [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
• 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 2
• 101710194728 Cytokine receptor-like factor 1 Proteins 0.000 description 2
• 208000034423 Delivery Diseases 0.000 description 2
• 102100021717 Early growth response protein 3 Human genes 0.000 description 2
• 102000016942 Elastin Human genes 0.000 description 2
• 108010014258 Elastin Proteins 0.000 description 2
• 102000003951 Erythropoietin Human genes 0.000 description 2
• 108090000394 Erythropoietin Proteins 0.000 description 2
• 101000924488 Homo sapiens Atrial natriuretic peptide receptor 3 Proteins 0.000 description 2
• 101000896450 Homo sapiens Early growth response protein 3 Proteins 0.000 description 2
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
• 150000008575 L-amino acids Chemical class 0.000 description 2
• 102100039564 Leukosialin Human genes 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• 108090001109 Thermolysin Proteins 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 108091009550 Vesicle-associated membrane protein 5 Proteins 0.000 description 2
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 230000001070 adhesive effect Effects 0.000 description 2
• 210000000577 adipose tissue Anatomy 0.000 description 2
• 210000004504 adult stem cell Anatomy 0.000 description 2
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 230000001857 anti-mycotic effect Effects 0.000 description 2
• 239000002543 antimycotic Substances 0.000 description 2
• 238000012865 aseptic processing Methods 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000002459 blastocyst Anatomy 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 238000005266 casting Methods 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 238000011072 cell harvest Methods 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 230000003081 coactivator Effects 0.000 description 2
• 230000000052 comparative effect Effects 0.000 description 2
• CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 229920002549 elastin Polymers 0.000 description 2
• 210000002308 embryonic cell Anatomy 0.000 description 2
• 230000006862 enzymatic digestion Effects 0.000 description 2
• 229940105423 erythropoietin Drugs 0.000 description 2
• 238000005530 etching Methods 0.000 description 2
• 229940031098 ethanolamine Drugs 0.000 description 2
• 210000002744 extracellular matrix Anatomy 0.000 description 2
• 210000003953 foreskin Anatomy 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 238000002386 leaching Methods 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 210000005087 mononuclear cell Anatomy 0.000 description 2
• 210000002894 multi-fate stem cell Anatomy 0.000 description 2
• QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 230000036542 oxidative stress Effects 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
• 239000008055 phosphate buffer solution Substances 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 108010055896 polyornithine Proteins 0.000 description 2
• 229920002714 polyornithine Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
• 230000035935 pregnancy Effects 0.000 description 2
• 238000003825 pressing Methods 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 229940082569 selenite Drugs 0.000 description 2
• MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 2
• 239000004017 serum-free culture medium Substances 0.000 description 2
• 235000017557 sodium bicarbonate Nutrition 0.000 description 2
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 235000019155 vitamin A Nutrition 0.000 description 2
• 239000011719 vitamin A Substances 0.000 description 2
• 229940045997 vitamin a Drugs 0.000 description 2
• DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 description 1
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
• QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
• UPLLQJUZZIYKHI-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;2-oxobutanedioic acid Chemical compound OC(=O)CC(=O)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O UPLLQJUZZIYKHI-DFWYDOINSA-N 0.000 description 1
• 101150084750 1 gene Proteins 0.000 description 1
• WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 102100024394 Adipocyte enhancer-binding protein 1 Human genes 0.000 description 1
• 101710105604 Adipocyte enhancer-binding protein 1 Proteins 0.000 description 1
• 101710186708 Agglutinin Proteins 0.000 description 1
• 102000005602 Aldo-Keto Reductases Human genes 0.000 description 1
• 108010084469 Aldo-Keto Reductases Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
• 102100034608 Angiopoietin-2 Human genes 0.000 description 1
• 108010048036 Angiopoietin-2 Proteins 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 101100457310 Arabidopsis thaliana MIP1A gene Proteins 0.000 description 1
• 108091012583 BCL2 Proteins 0.000 description 1
• 102100037140 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Human genes 0.000 description 1
• 102000004954 Biglycan Human genes 0.000 description 1
• 108090001138 Biglycan Proteins 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 102100036845 C-C motif chemokine 22 Human genes 0.000 description 1
• 102100031092 C-C motif chemokine 3 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 1
• 108700012434 CCL3 Proteins 0.000 description 1
• 101150116911 CCL3 gene Proteins 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 1
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 1
• 108010014423 Chemokine CXCL6 Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 102100024337 Collagen alpha-1(VIII) chain Human genes 0.000 description 1
• 241001665400 Coracias abyssinicus Species 0.000 description 1
• 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 description 1
• 102100025629 Cytochrome c oxidase subunit 7A1, mitochondrial Human genes 0.000 description 1
• 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
• 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102100032883 DNA-binding protein SATB2 Human genes 0.000 description 1
• 238000008789 Direct Bilirubin Methods 0.000 description 1
• 206010013883 Dwarfism Diseases 0.000 description 1
• 102000018386 EGF Family of Proteins Human genes 0.000 description 1
• 108010066486 EGF Family of Proteins Proteins 0.000 description 1
• 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
• 102100033167 Elastin Human genes 0.000 description 1
• 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
• 108010055191 EphA3 Receptor Proteins 0.000 description 1
• 102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 1
• 102100031758 Extracellular matrix protein 1 Human genes 0.000 description 1
• 101710127949 Extracellular matrix protein 1 Proteins 0.000 description 1
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 1
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 102000001002 Frizzled-7 Human genes 0.000 description 1
• 102100039676 Frizzled-7 Human genes 0.000 description 1
• 108050007985 Frizzled-7 Proteins 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 108010024164 HLA-G Antigens Proteins 0.000 description 1
• 241000193159 Hathewaya histolytica Species 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
• 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 1
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 1
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
• 102000052396 Hephaestin Human genes 0.000 description 1
• 108700038053 Hephaestin Proteins 0.000 description 1
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
• 102100029279 Homeobox protein SIX1 Human genes 0.000 description 1
• 102100027332 Homeobox protein SIX2 Human genes 0.000 description 1
• 101000690306 Homo sapiens Aldo-keto reductase family 1 member C3 Proteins 0.000 description 1
• 101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
• 101000740545 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Proteins 0.000 description 1
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 1
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101000909492 Homo sapiens Collagen alpha-1(VIII) chain Proteins 0.000 description 1
• 101000856748 Homo sapiens Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 1
• 101000655236 Homo sapiens DNA-binding protein SATB2 Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 1
• 101000634171 Homo sapiens Homeobox protein SIX1 Proteins 0.000 description 1
• 101000651912 Homo sapiens Homeobox protein SIX2 Proteins 0.000 description 1
• 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 description 1
• 101000997670 Homo sapiens Integrin beta-8 Proteins 0.000 description 1
• 101001003147 Homo sapiens Interleukin-11 receptor subunit alpha Proteins 0.000 description 1
• 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 description 1
• 101000977762 Homo sapiens Iroquois-class homeodomain protein IRX-5 Proteins 0.000 description 1
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
• 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
• 101000612134 Homo sapiens Procollagen C-endopeptidase enhancer 1 Proteins 0.000 description 1
• 101000736906 Homo sapiens Protein prune homolog 2 Proteins 0.000 description 1
• 101000880310 Homo sapiens SH3 and cysteine-rich domain-containing protein Proteins 0.000 description 1
• 101000703741 Homo sapiens Short stature homeobox protein 2 Proteins 0.000 description 1
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000626125 Homo sapiens Tetranectin Proteins 0.000 description 1
• 101710146024 Horcolin Proteins 0.000 description 1
• 108050009363 Hyaluronidases Proteins 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 102000014429 Insulin-like growth factor Human genes 0.000 description 1
• 102100033016 Integrin beta-7 Human genes 0.000 description 1
• 102100033336 Integrin beta-8 Human genes 0.000 description 1
• 102100020787 Interleukin-11 receptor subunit alpha Human genes 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 description 1
• 102100023529 Iroquois-class homeodomain protein IRX-5 Human genes 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• 101710189395 Lectin Proteins 0.000 description 1
• 102000011965 Lipoprotein Receptors Human genes 0.000 description 1
• 108010061306 Lipoprotein Receptors Proteins 0.000 description 1
• 102000009151 Luteinizing Hormone Human genes 0.000 description 1
• 108010073521 Luteinizing Hormone Proteins 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 101710179758 Mannose-specific lectin Proteins 0.000 description 1
• 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
• 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• GKWTZACONBQTNK-IVIZKJKWSA-N N-benzyl-7H-purin-6-amine (1R,2R,5R,8R,9S,10R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid (1R,2R,5R,8R,9S,10R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid Chemical compound C(Nc1ncnc2nc[nH]c12)c1ccccc1.CC12[C@H]3[C@H](C(O)=O)[C@@]45C[C@@H](CC[C@H]4[C@@]3(CC[C@@H]1O)OC2=O)C(=C)C5.CC12[C@H]3[C@H](C(O)=O)[C@@]45C[C@@H](CC[C@H]4[C@]3(OC1=O)C=C[C@@H]2O)C(=C)C5 GKWTZACONBQTNK-IVIZKJKWSA-N 0.000 description 1
• 102000002452 NPR3 Human genes 0.000 description 1
• 101150066297 NPR3 gene Proteins 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 1
• 101150093908 PDGFRB gene Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 102000003982 Parathyroid hormone Human genes 0.000 description 1
• 108090000445 Parathyroid hormone Proteins 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 101000931422 Photobacterium phosphoreum Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
• NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
• 102100041026 Procollagen C-endopeptidase enhancer 1 Human genes 0.000 description 1
• 102100038931 Proenkephalin-A Human genes 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
• 102000003946 Prolactin Human genes 0.000 description 1
• 108010057464 Prolactin Proteins 0.000 description 1
• 108010065942 Prostaglandin-F synthase Proteins 0.000 description 1
• 101710196640 Protein 3.8 Proteins 0.000 description 1
• 102100036040 Protein prune homolog 2 Human genes 0.000 description 1
• 241000508269 Psidium Species 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• 239000012979 RPMI medium Substances 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 102100025369 Runt-related transcription factor 3 Human genes 0.000 description 1
• 102100037646 SH3 and cysteine-rich domain-containing protein Human genes 0.000 description 1
• 101000752546 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Transaminated amino acid decarboxylase Proteins 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 208000020221 Short stature Diseases 0.000 description 1
• 102100031976 Short stature homeobox protein 2 Human genes 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 229920002385 Sodium hyaluronate Polymers 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
• 208000002220 Supravalvular aortic stenosis Diseases 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 102000007000 Tenascin Human genes 0.000 description 1
• 108010008125 Tenascin Proteins 0.000 description 1
• 102100024554 Tetranectin Human genes 0.000 description 1
• 108010041111 Thrombopoietin Proteins 0.000 description 1
• 102000036693 Thrombopoietin Human genes 0.000 description 1
• 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
• 102000003929 Transaminases Human genes 0.000 description 1
• 108090000340 Transaminases Proteins 0.000 description 1
• 108010048999 Transcription Factor 3 Proteins 0.000 description 1
• 102100038313 Transcription factor E2-alpha Human genes 0.000 description 1
• 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
• TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
• 229930003779 Vitamin B12 Natural products 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 210000002593 Y chromosome Anatomy 0.000 description 1
• MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
• PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 239000000910 agglutinin Substances 0.000 description 1
• 230000000735 allogeneic effect Effects 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
• 239000003146 anticoagulant agent Substances 0.000 description 1
• 229940127219 anticoagulant drug Drugs 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 239000012503 blood component Substances 0.000 description 1
• 238000004820 blood count Methods 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 229940105657 catalase Drugs 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000000919 ceramic Substances 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 230000001112 coagulating effect Effects 0.000 description 1
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 229960003624 creatine Drugs 0.000 description 1
• 239000006046 creatine Substances 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 238000004163 cytometry Methods 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 230000032459 dedifferentiation Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 229940119679 deoxyribonucleases Drugs 0.000 description 1
• 210000004207 dermis Anatomy 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 210000003981 ectoderm Anatomy 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 210000001900 endoderm Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000000646 extraembryonic cell Anatomy 0.000 description 1
• 210000002219 extraembryonic membrane Anatomy 0.000 description 1
• 239000004744 fabric Substances 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 210000000604 fetal stem cell Anatomy 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 210000001654 germ layer Anatomy 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 210000003566 hemangioblast Anatomy 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920002674 hyaluronan Polymers 0.000 description 1
• 229960003160 hyaluronic acid Drugs 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 229960000890 hydrocortisone Drugs 0.000 description 1
• 210000003692 ilium Anatomy 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 229940040129 luteinizing hormone Drugs 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 235000018977 lysine Nutrition 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 210000001349 mammary artery Anatomy 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 238000011177 media preparation Methods 0.000 description 1
• 239000012533 medium component Substances 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 101150029117 meox2 gene Proteins 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 230000000921 morphogenic effect Effects 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 230000035764 nutrition Effects 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 239000000199 parathyroid hormone Substances 0.000 description 1
• 229960001319 parathyroid hormone Drugs 0.000 description 1
• 229940056360 penicillin g Drugs 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 210000004786 perivascular cell Anatomy 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 108010005636 polypeptide C Proteins 0.000 description 1
• 235000015497 potassium bicarbonate Nutrition 0.000 description 1
• 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
• 239000011736 potassium bicarbonate Substances 0.000 description 1
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 108010041071 proenkephalin Proteins 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 229940097325 prolactin Drugs 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 229940076788 pyruvate Drugs 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000012340 reverse transcriptase PCR Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 229940091258 selenium supplement Drugs 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 229940010747 sodium hyaluronate Drugs 0.000 description 1
• YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
• 230000000920 spermatogeneic effect Effects 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 229960002385 streptomycin sulfate Drugs 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 210000002504 synaptic vesicle Anatomy 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 210000001042 thoracic artery Anatomy 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000012876 topography Methods 0.000 description 1
• 229940072041 transforming growth factor beta 2 Drugs 0.000 description 1
• 230000001228 trophic effect Effects 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 229940116269 uric acid Drugs 0.000 description 1
• 235000019163 vitamin B12 Nutrition 0.000 description 1
• 239000011715 vitamin B12 Substances 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 229910052727 yttrium Inorganic materials 0.000 description 1